EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%.
Media properties
- Themes
- Research and Tech Transfer , Cancer, STI, Research and Tech Transfer
- Copyright
- © Alain Herzog / EPFL
- Licence
- CC0 Licence
- Shooting date
- Dec. 7, 2021
- Album
- Rigidifying cancer cells for better immunotherapy
Share on